A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

December 17, 2026

Conditions

β-Thalassemia Major

Interventions

DRUG

Luspatercept

As per product label

Trial Locations (5)

Local Institution - 05, Taoyuan District

Local Institution - 04, Tainan City

Local Institution - 02, Kaohsiung City

Local Institution - 03, Taipei

Local Institution - 01, Taipei